← Back to patent-cliff list
CAS 1628174-84-4
3-Nitro-4-[[(2S)-1,4-dioxan-2-yl]methylamino]benzenesulfonamide
Codes: (XIX)992511-1-b,(XIX)992511-1-g
Application context (from source-drug indications)
Chronic lymphocytic leukaemiaLisaftoclaxAcute promyelocytic leukaemiaLisaftoclaxMyelodysplastic syndromeLisaftoclaxAcute myeloid leukaemiaLisaftoclaxDiffuse large B-cell lymphomaLisaftoclaxSystemic lupus erythematosusLisaftoclax
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Lisaftoclax | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
3-Nitro-4-[[(2S)-1,4-dioxan-2-yl]methylamino]benzenesulfonamide→7-(Chloromethyl)-6-(4-chlorophenyl)spiro[3.5]non-6-ene→Ethyl 2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-(piperazin-1 -yl)benzoate→Ethyl 4-(4-[[6-(4-chlorophenyl)spiro[3.5]non-6-en-7-yl]methyl]piperazin-1-yl)-2-[(1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]benzoate→4-(4-[[6-(4-Chlorophenyl)spiro[3.5]non-6-en-7-yl]methyl]piperazin-1-yl)-2-[(1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]benzoic acid
3-Nitro-4-[[(2S)-1,4-dioxan-2-yl]methylamino]benzenesulfonamide→(S)-2-Aminomethyl-1,4-dioxane hydrochlorid→3-Nitro-4-chlorobenzensulfonyl amine
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.